A majority of Canadians, health-care providers, labour organizations and employers agree a national single-payer system is an idea whose time has come, according to a report by the Broadbent Institute. Canada has attempted to bring in a national pharmacare plan nine times in the last 73 years — in 1945, 1947, 1962, 1964, 1966, 1970, 1997, 2002, and […]
While a national pharmacare program in Canada could mean reduced expenditures and drug prices, there could also be unintended consequences, according to a new report by the Fraser Institute. Shining a light on the national programs in Australia, New Zealand and U.K., the report looked at the cost-saving mechanisms they use, as well as the side-effects. Specifically, it noted the programs […]
In its 2018 budget, the federal government created an advisory council on the implementation of national pharmacare, led by former Ontario health minister Eric Hoskins. The council, which solicited submissions from Canadians between June and September, is expected to release its final report in the spring. Whatever the report recommends, Canada is closer to a […]
Private drug plans are hugely valuable, for employees and employers alike, and they need to continue to be a part of the national drug landscape, even with a pharmacare program, said one speaker at the 2018 Calgary Drug Trends Summit. At the same time, drug costs are creating sustainability issues, said Sarah Lussier Hoskyn, senior analyst of […]
The national pharmacare debate is lacking a clear understanding of the coverage already available to Canadians who may be at risk of letting prescriptions go unfilled because of cost, according to a new report by the Fraser Institute. Looking at provincial drug programs across Canada, the report noted British Columbia’s pharmacare plan covers 70 per cent of eligible prescription drugs […]
Any decision reached on pharmacare reform in Canada should guarantee the viability of current health benefits plans, according to the Canadian Life and Health Insurance Association in its submission to the advisory council on the implementation of national pharmacare. Jeopardizing current benefits plans could lead to a delay in access to new medicines and could potentially […]
The issue of a national pharmacare program is more nuanced than it may appear at first glance, said Joe Farago during a presentation at the 2018 Halifax Benefits Summit on Sept. 20. “Canadians are starting to change their views,” said Innovative Medicines Canada’s executive director, private payers and investment, during the conference. Farago pointed to a national poll of health-care providers, managers and the […]
A coalition comprised of dozens of federal and provincial health-care organizations, including providers, patient groups, academics, health practitioner unions and professional associations, have teamed up to create a set of principles for national pharmacare in Canada. First, the coaltion believes pharmacare should work as a clear extension of Canada’s current universal health-care system, bringing pharmaceutical services in […]
The results of the ongoing renegotiations of the North American Free Trade Agreement could have an impact on how much Canadians pay for their medications in the future, according to one expert. In an article originally published by not-for-profit media outlet the Conversation, Joel Lexchin, an associate professor of family and community medicine at the University of Toronto, pointed out that the […]
Universal pharmacare is an idea that has been kicking around for decades in Canada. Yet despite numerous studies calling for a universal single-payer pharmacare program to ensure all Canadians have access to prescription drugs, the country’s drug system remains a patchwork of public and private plans. This spring, the House of Commons’ standing committee on […]